CRM Publications

Stoffels JMJ, de Jonge JC, Stancic M, Nomden A, van Strien ME, Ma D, Sisková Z, Maier O, ffrench-Constant C, Franklin RJM et al..  2013.  Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.Brain. 136(Pt 1):116-31.

Yuen TJ, Johnson KR, Miron VE, Zhao C, Quandt J, Harrisingh MC, Swire M, Williams AC, McFarland HF, Franklin RJM et al..  2013.  Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination.Brain. 136(Pt 4):1035-47.

Miron VE, Boyd A, Zhao J-W, Yuen TJ, Ruckh JM, Shadrach JL, van Wijngaarden P, Wagers AJ, Williams AC, Franklin RJM et al..  2013.  M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination.Nat Neurosci. 16(9):1211-8.

Jarjour AA, Zhang H, Bauer N, ffrench-Constant C, Williams AC.  2012.  In vitro modeling of central nervous system myelination and remyelination.Glia. 60(1):1-12.

Zhang H, Jarjour AA, Boyd A, Williams AC.  2011.  Central nervous system remyelination in culture--a tool for multiple sclerosis research.Exp Neurol. 230(1):138-48.

Stankoff B, Freeman L, Aigrot M-S, Chardain A, Dollé F, Williams AC, Galanaud D, Armand L, Lehericy S, Lubetzki C et al..  2011.  Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-¹¹C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole.Ann Neurol. 69(4):673-80.

Huang JK, Jarjour AA, Oumesmar BNait, Kerninon C, Williams AC, Krezel W, Kagechika H, Bauer J, Zhao C, Van Evercooren ABaron- et al..  2011.  Retinoid X receptor gamma signaling accelerates CNS remyelination.Nat Neurosci. 14(1):45-53.

Huang JK, Jarjour AA, ffrench-Constant C, Franklin RJM.  2011.  Retinoid X receptors as a potential avenue for regenerative medicine in multiple sclerosis.Expert Rev Neurother. 11(4):467-8.

Baer AS, Syed YA, Kang SUng, Mitteregger D, Vig R, ffrench-Constant C, Franklin RJM, Altmann F, Lubec G, Kotter MR.  2009.  Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling.Brain. 132(Pt 2):465-81.

Zhao C, Fancy SPJ, Franklin RJM, ffrench-Constant C.  2009.  Up-regulation of oligodendrocyte precursor cell alphaV integrin and its extracellular ligands during central nervous system remyelination.J Neurosci Res. 87(15):3447-55.

Hunt DPJ, Irvine KA, Webber DJ, Compston DAS, Blakemore WF, Chandran S.  2008.  Effects of direct transplantation of multipotent mesenchymal stromal/stem cells into the demyelinated spinal cord.Cell Transplant. 17(7):865-73.

Chandran S, Hunt DPJ, Joannides A, Zhao C, Compston A, Franklin RJM.  2008.  Myelin repair: the role of stem and precursor cells in multiple sclerosis.Philos Trans R Soc Lond B Biol Sci. 363(1489):171-83.

Zhao C, Fancy SPJ, ffrench-Constant C, Franklin RJM.  2008.  Osteopontin is extensively expressed by macrophages following CNS demyelination but has a redundant role in remyelination.Neurobiol Dis. 31(2):209-17.

Franklin RJM, ffrench-Constant C.  2008.  Remyelination in the CNS: from biology to therapy.Nat Rev Neurosci. 9(11):839-55.

Tapinos N, Ohnishi M, Rambukkana A.  2006.  ErbB2 receptor tyrosine kinase signaling mediates early demyelination induced by leprosy bacilli.Nat Med. 12(8):961-6.

Chandran S, Compston A.  2005.  Neural stem cells as a potential source of oligodendrocytes for myelin repair.J Neurol Sci. 233(1-2):179-81.

Chandran S, Compston A, Jauniaux E, Gilson J, Blakemore W, Svendsen C.  2004.  Differential generation of oligodendrocytes from human and rodent embryonic spinal cord neural precursors.Glia. 47(4):314-24.

Rambukkana A, Zanazzi G, Tapinos N, Salzer JL.  2002.  Contact-dependent demyelination by Mycobacterium leprae in the absence of immune cells.Science. 296(5569):927-31.

Gillespie CS, Sherman DL, Fleetwood-Walker SM, Cottrell DF, Tait S, Garry EM, Wallace VC, Ure J, Griffiths IR, Smith A et al..  2000.  Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice.Neuron. 26(2):523-31.